Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 Inhalation for Apnea of Prematurity
NCT01066728Phase 3Completed
- Sponsor
- University of Manitoba
- Start
- Aug 2001
- Primary completion
- Sep 2005
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of Carbon dioxide in apnea of prematurity (AOP), sponsored by University of Manitoba. Started Aug 2001; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT01066728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066728.